Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule I:

         1. See Wisconsin Statutes 961.01

Following: when used by way of reference to any statute section, means the section next following that in which the reference is made. See Wisconsin Statutes 990.01

Gamma-butyrolactone: means gamma-butyrolactone as packaged, marketed, manufactured, or promoted for human consumption, but does not include gamma-butyrolactone intended for use or consumption in or for mechanical, industrial, manufacturing, or scientific applications or purposes. See Wisconsin Statutes 961.01

isomer: includes any geometric isomer; in…. See Wisconsin Statutes 961.01

Manufacture: means the production, preparation, propagation, compounding, conversion or processing of, or to produce, prepare, propagate, compound, convert or process, a controlled substance or controlled substance analog, directly or indirectly, by extraction from substances of natural origin, chemical synthesis or a combination of extraction and chemical synthesis, including to package or repackage or the packaging or repackaging of the substance, or to label or to relabel or the labeling or relabeling of its container. See Wisconsin Statutes 961.01

Marijuana: means all parts of the plants of the genus Cannabis, whether growing or not; the seeds thereof; the resin extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture or preparation of the plant, its seeds or resin, including tetrahydrocannabinols. See Wisconsin Statutes 961.01

State: when applied to states of the United States, includes the District of Columbia, the commonwealth of Puerto Rico and the several territories organized by Congress. See Wisconsin Statutes 990.01

United States: includes the District of Columbia, the states, the commonwealth of Puerto Rico and the territories organized by congress. See Wisconsin Statutes 990.01

   (2)   Synthetic opiates. Any material, compound, mixture or preparation which contains any quantity of any of the following synthetic opiates, including any of their isomers, esters, ethers, esters and ethers of isomers, salts and salts of isomers, esters, ethers and esters and ethers of isomers that are theoretically possible within the specific chemical designation:

      (ag)    Acetylmethadol;

      (aj)    AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide);

      (am)    Allylprodine;

      (b)    Alphacetylmethadol (except levo-alphacetylmethadol (LAAM));

      (bm)    Alphameprodine;

      (c)    Alphamethadol;

      (cm)    Benzethidine;

      (d)    Betacetylmethadol;

      (dm)    Betameprodine;

      (e)    Betamethadol;

      (em)    Betaprodine;

      (et)    Brorphine;

      (f)    Clonitazene;

      (fm)    Dextromoramide;

      (gm)    Diampromide;

      (h)    Diethylthiambutene;

      (hg)    Difenoxin;

      (hm)    Dimenoxadol;

      (j)    Dimepheptanol;

      (jm)    Dimethylthiambutene;

      (k)    Dioxaphetyl butyrate;

      (km)    Dipipanone;

      (m)    Ethylmethylthiambutene;

      (n)    Etoxeridine;

      (nd)    Fentanyl analogs, including any compound, except compounds scheduled elsewhere in this chapter, structurally derived from fentanyl by replacement of the phenyl portion of the phenethyl group by any monocycle whether or not further substituted in or on the monocycle; by substitution in or on the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halo, haloalkyl, amino or nitro groups; by substitution in or on the piperidine ring with alkyl, alkenyl, alkoxy, ester, ether, hydroxy, halo, haloalkyl, amino or nitro groups; by replacement of the aniline ring with any aromatic monocycle whether or not further substituted in or on the aromatic monocycle; by replacement of the N-propionyl group by another acyl group; or by any combination of these modifications. Substances specified under this paragraph include all of the following:

         1.    Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2- phenylethyl)-4-piperidinyl]-N-phenylacetamide);

         2.    Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylacetamide);

         3.    Acryl fentanyl (N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-2-propenamide);

         3m.    Alpha-methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide);

         4.    Alpha-methylfentanyl (N-[1-(1-methyl-2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide);

         5.    Alpha-methylthiofentanyl (N-{1-[1-methyl-2-(2-thienyl)ethyl]-4-piperidinyl}-N-phenylpropanamide);

         6.    Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide);

         7.    Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy- 2-phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);

         8.    Beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide);

         9.    Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide);

         9m.    Crotonyl Fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2- enamide);

         10.    Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide);

         10d.    Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide);

         10m.    2′,5′-dimethoxyfentanyl (N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide);

         10p.    4-fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]-butyramide);

         10t.    4-fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);

         11.    Furanyl fentanyl (N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide);

         11m.    3-furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide);

         12.    Isobutyryl fentanyl (2-methyl-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-propanamide);

         12e.    Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide);

         12m.    Meta-fluorofentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide);

         12s.    Meta-fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);

         12w.    Methoxyacetyl fentanyl (2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-acetamide);

         12y.    3-methylbutyryl fentanyl (N-[3-methyl-1-(2-phenylethyl)piperidin-4-yl]-N-phenylbutyramide);

         13.    4-methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide);

         14.    3-methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4- piperidinyl]-N-phenylpropanamide);

         15.    3-methylthiofentanyl (N-{3-methyl-1-[2-(2-thienyl)ethyl]-4-piperidinyl}-N-phenylpropanamide);

         16.    Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N-[1-(2-phenylethyl)piperidin-4-yl]-acetamide);

         16m.    Ortho-fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide);

         16n.    Ortho-fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);

         16s.    Para-chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);

         17.    Para-fluorofentanyl (N-[1-(2-phenylethyl)-4-piperidinyl]-N-(4-fluorophenyl)propanamide);

         17g.    Para-methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);

         17r.    Para-methylcyclopropyl fentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide);

         18.    Tetrahydrofuran fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide);

         19.    Thiofentanyl (N-{1-[2-(2-thienyl)ethyl]-4-piperidinyl}-N-phenylpropanamide);

         20.    Valeryl fentanyl (N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]pentanamide);

         21.    N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide (2′-fluoro ortho-fluorofentanyl; 2′-fluoro 2-fluorofentanyl);

         22.    N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide (4′-methyl acetyl fentanyl);

         23.    N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide (b‘-phenyl fentanyl; beta’-Phenyl fentanyl; 3-phenylpropanoyl fentanyl);

         24.    N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide (b-methyl fentanyl);

         25.    N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide (ortho-fluorobutyryl fentanyl; 2-fluorobutyryl fentanyl);

         26.    N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide (ortho-methyl acetylfentanyl; 2-methyl acetylfentanyl);

         27.    2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide (ortho-methyl methoxyacetylfentanyl; 2-methyl methoxyacetyl fentanyl);

         28.    N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide (para-methylfentanyl; 4-methylfentanyl);

         29.    N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide (phenyl fentanyl; benzoyl fentanyl);

         30.    N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide (thiofuranyl fentanyl; 2-thiofuranyl fentanyl; thiophene fentanyl).

      (nm)    Furethidine;

      (p)    Hydroxypethidine;

      (pm)    Ketobemidone;

      (q)    Levomoramide;

      (qm)    Levophenacylmorphan;

      (r)    Morpheridine;

      (rg)    MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);

      (rk)    MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine);

      (rm)    Noracymethadol;

      (s)    Norlevorphanol;

      (sm)    Normethadone;

      (t)    Norpipanone;

      (tm)    Phenadoxone;

      (u)    Phenampromide;

      (um)    Phenomorphan;

      (v)    Phenoperidine;

      (vg)    PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine);

      (vm)    Piritramide;

      (w)    Proheptazine;

      (wm)    Properidine;

      (wn)    Propiram;

      (x)    Racemoramide;

      (xm)    Synthetic Benzimidazole-opioid Substances, specifically including all of the following:

         1.    Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1- amine).

         2.    Etodesnitazene also known as Etazene (2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1- amine).

         3.    Etonitazene (2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1- amine).

         4.    Flunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5- nitro-1H-benzimidazol-1-yl)ethan-1- amine).

         5.    Isotonitazene (N,N -diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benizimidazol-1-yl)ethan-1-amine).

         6.    Metodesnitazene (N,N-diethyl-2-(2-(4- methoxybenzyl)-1H-benzimidazol-1- yl)ethan-1-amine).

         7.    Metonitazene (N,N-diethyl-2-(2-(4- methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine).

         8.    N-pyrrolidino etonitazene also known as etonitazepyne (2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole).

         9.    Protonitazene (N,N-diethyl-2-(5-nitro-2-(4- propoxybenzyl)-1H-benzimidazol-1- yl)ethan-1-amine).

      (xr)    Tilidine;

      (y)    Trimeperidine.

      (z)    U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide).

      (zm)    Zipeprol (1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol).

   (3)   Substances derived from opium. Any material, compound, mixture or preparation which contains any quantity of any of the following substances derived from opium, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:

      (a)    Acetorphine;

      (b)    Acetyldihydrocodeine;

      (c)    Benzylmorphine;

      (d)    Codeine methylbromide;

      (e)    Codeine-N-oxide;

      (f)    Cyprenorphine;

      (g)    Desomorphine;

      (h)    Dihydromorphine;

      (hm)    Drotebanol;

      (j)    Etorphine, except its hydrochloride salts;

      (k)    Heroin;

      (m)    Hydromorphinol;

      (n)    Methyldesorphine;

      (p)    Methyldihydromorphine;

      (q)    Morphine methylbromide;

      (r)    Morphine methylsulfonate;

      (s)    Morphine-N-oxide;

      (t)    Myrophine;

      (u)    Nicocodeine;

      (v)    Nicomorphine;

      (w)    Normorphine;

      (x)    Pholcodine;

      (y)    Thebacon.

   (4)   Hallucinogenic substances. Any material, compound, mixture or preparation which contains any quantity of any of the following hallucinogenic substances, including any of their salts, isomers, esters, ethers, and salts of isomers, esters, or ethers that are theoretically possible within the specific chemical designation, in any form contained in a plant, obtained from a plant, or chemically synthesized:

      (a)    3,4-methylenedioxyamphetamine, commonly known as “MDA”;

      (ag)    3,4-methylenedioxyethylamphetamine, commonly known as “MDE”;

      (am)    3,4-methylenedioxymethamphetamine, commonly known as “MDMA”;

      (ar)    N-hydroxy-3,4-methylenedioxyamphetamine;

      (b)    5-methoxy-3,4-methylenedioxyamphetamine;

      (bm)    4-ethyl-2,5-dimethoxyamphetamine, commonly known as “DOET”;

      (c)    3,4,5-trimethoxyamphetamine;

      (cm)    Alpha-ethyltryptamine;

      (d)    Bufotenine;

      (e)    Diethyltryptamine;

      (f)    Dimethyltryptamine;

      (g)    4-methyl-2,5-dimethoxyamphetamine, commonly known as “STP”;

      (h)    Ibogaine;

      (j)    Lysergic acid diethylamide, commonly known as “LSD”;

      (jm)    1-propionyl-lysergic acid diethylamide, commonly known as 1P-LSD;

      (m)    Mescaline, in any form, including mescaline contained in peyote, obtained from peyote or chemically synthesized;

      (mn)    Parahexyl (3-hexyl-1-hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo(b, d)pyran);

      (n)    Phencyclidine, commonly known as “PCP”;

      (p)    N-ethyl-3-piperidyl benzilate;

      (q)    N-methyl-3-piperidyl benzilate;

      (r)    Psilocybin;

      (s)    Psilocin;

      (sm)    Salvinorin A;

      (t)    Tetrahydrocannabinols, commonly known as “THC”, in any form including tetrahydrocannabinols contained in marijuana, obtained from marijuana, or chemically synthesized, except that tetrahydrocannabinols do not include any of the following:

         1.    Tetrahydrocannabinols contained in a cannabidiol product that is dispensed as provided in s. 961.38 (1n) (a) or that is possessed as provided in s. 961.32 (2m) (b).

         2.    Tetrahydrocannabinols contained in fiber produced from the stalks, oil or cake made from the seeds of a Cannabis plant, any other compound, manufacture, salt, derivative, mixture or preparation of the mature stalks (except the resin extracted therefrom), fiber, oil or cake or the sterilized seed of a Cannabis plant which is incapable of germination.

         3.    Tetrahydrocannabinols contained in hemp, as defined in s. 94.55 (1).

         4.    A drug product in finished dosage formulation that has been approved by the United States food and drug administration that contains cannabidiol (2-[1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol) derived from cannabis and no more than 0.1 percent (w/w) residual tetrahydrocannabinols.

      (tb)    Synthetic cannabinoids, including:

         1.    Any compound structurally derived from 3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the naphthyl ring to any extent. Substances specified under this subdivision include:

            a.    1-pentyl-2-methyl-3-(1-naphthoyl)indole, commonly known as JWH-007;

            b.    1-propyl-2-methyl-3-(1-naphthoyl)indole, commonly known as JWH-015;

            c.    1-pentyl-3-(1-naphthoyl)indole, commonly known as JWH-018 or AM-678;

            d.    1-hexyl-3-(1-naphthoyl)indole, commonly known as JWH-019;

            e.    1-butyl-3-(1-naphthoyl)indole, commonly known as JWH-073;

            f.    1-pentyl-3-(4-methoxy-1-naphthoyl)indole, commonly known as JWH-081;

            g.    1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole, commonly known as JWH-098;

            h.    1-pentyl-3-(4-methyl-1-naphthoyl)indole, commonly known as JWH-122;

            i.    1-pentyl-3-(7-methoxy-1-naphthoyl)indole, commonly known as JWH-164;

            j.    1-[2-(4-(morpholinyl)ethyl)]-3-(1-naphthoyl)indole, commonly known as JWH-200;

            k.    1-pentyl-3-(4-ethyl-1-naphthoyl)indole, commonly known as JWH-210;

            L.    1-pentyl-3-(4-chloro-1-naphthoyl)indole, commonly known as JWH-398;

            m.    1-pentyl-3-(4-fluoro-1-naphthoyl)indole, commonly known as JWH-412;

            n.    1-[1-(N-methyl-2-piperidinyl)methyl]-3-(1-naphthoyl)indole, commonly known as AM-1220;

            o.    1-(5-fluoropentyl)-3-(1-naphthoyl)indole, commonly known as AM-2201;

            p.    1-(5-fluoropentyl)-3-(4-methyl-1-naphthoyl)indole, commonly known as MAM-2201;

            q.    1-(5-chloropentyl)-3-(1-naphthoyl)indole, commonly known as AM-2201 (5-chloropentyl);

            r.    1-(5-bromopentyl)-3-(1-naphthoyl)indole, commonly known as AM-2201 (5-bromopentyl);

            s.    1-(4-cyanobutyl)-3-(1-naphthoyl)indole, commonly known as AM-2232;

            t.    (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenyl-methanone, commonly known as WIN 55,212-2;

         2.    Any compound structurally derived from 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted in the naphthyl ring to any extent. Substances specified under this subdivision include:

            a.    1-pentyl-5-(2-fluorophenyl)-3-(1-naphthoyl)pyrrole, commonly known as JWH-307;

            b.    1-pentyl-5-(2-methylphenyl)-3-(1-naphthoyl)pyrrole, commonly known as JWH-370;

            c.    1-pentyl-3-(1-naphthoyl)pyrrole, commonly known as JWH-030;

            d.    1-hexyl-5-phenyl-3-(1-naphthoyl)pyrrole, commonly known as JWH-147;

         3.    Any compound structurally derived from 3-naphthylmethylindene by substitution at the 1-position of the indene ring by alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring to any extent. Substances specified under this subdivision include 1-pentyl-3-(1-naphthylmethyl)indene, commonly known as JWH-176;

         4.    Any compound structurally derived from 3-phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent. Substances specified under this subdivision include:

            a.    1-pentyl-3-(4-methoxyphenylacetyl)indole, commonly known as JWH-201;

            b.    1-pentyl-3-(3-methoxyphenylacetyl)indole, commonly known as JWH-302;

            c.    1-pentyl-3-(2-methoxyphenylacetyl)indole, commonly known as JWH-250;

            d.    1-pentyl-3-(2-chlorophenylacetyl)indole, commonly known as JWH-203;

            e.    1-pentyl-3-(3-chlorophenylacetyl)indole, or 3-chloro isomer of JWH-203;

            f.    1-pentyl-3-(4-chlorophenylacetyl)indole, or 4-chloro isomer of JWH-203;

            g.    1-pentyl-3-(2-methylphenylacetyl)indole, commonly known as JWH-251;

            h.    1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole, commonly known as RCS-8;

            i.    1-[1-(N-methyl-2-piperidinyl)methyl]-3-(2-methoxyphenylacetyl)indole, commonly known as cannabipiperidiethanone;

         5.    Any compound structurally derived from 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of the phenolic ring by alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not substituted in the cyclohexyl ring to any extent. Substances specified under this subdivision include:

            a.    2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol, commonly known as CP 47,497;

            b.    2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methylnonan-2-yl)phenol, commonly known as CP 47,497 C8 homologue, or cannabicyclohexanol;

         6.    Any compound structurally derived from 3-(benzoyl)indole by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Substances specified under this subdivision include:

            a.    1-pentyl-3-(2-iodobenzoyl)indole, commonly known as AM-679;

            b.    1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole, commonly known as AM-694;

            c.    1-pentyl-3-(4-methoxybenzoyl)indole, commonly known as RCS-4;

            d.    1-butyl-3-(4-methoxybenzoyl)indole, commonly known as RCS-4-C4 homologue;

            e.    1-pentyl-3-(2-methoxybenzoyl)indole, commonly known as RCS-4 2-methoxy isomer;

            f.    1-butyl-3-(2-methoxybenzoyl)indole, a C4 homologue, 2-methoxy isomer of RCS-4;

            g.    1-[2-(4-(morpholinyl)ethyl]-2-methyl-3-(4-methoxybenzoyl)indole, commonly known as pravadoline, or WIN 48,098;

            h.    1-[2-(4-(morpholinyl)ethyl]-2-methyl-3-(4-methoxybenzoyl)-6-iodo-indole, commonly known as 6-iodopravadoline, or AM-630;

            i.    1-[1-(N-methyl-2-piperidinyl)methyl]-3-(2-iodo-5-nitrobenzoyl)indole, commonly known as AM-1241;

            j.    1-[1-(N-methyl-2-piperidinyl)methyl]-3-(2-iodobenzoyl)indole, commonly known as AM-2233;

         7.    Any compound structurally derived from 3-adamantoylindole by substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the adamantyl ring to any extent. Substances specified under this subdivision include:

            a.    1-[1-(N-methyl-2-piperidinyl)methyl]-3-(1-adamantoyl)indole, commonly known as AM-1248;

            b.    1-pentyl-3-(1-adamantoyl)indole, commonly known as AB-001;

         8.    Any compound structurally derived from 3-(cyclopropoyl)indole by substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the cyclopropyl ring to any extent. Substances specified under this subdivision include:

            a.    1-pentyl-3-(2,2,3,3-tetramethylcyclopropoyl)indole, commonly known as UR-144;

            b.    1-(5-chloropentyl)-3-(2,2,3,3-tetramethylcyclopropoyl)indole, commonly known as 5Cl-UR-144;

            c.    1-(5-fluoropentyl)-3-(2,2,3,3-tetramethylcyclopropoyl)indole, commonly known as XLR-11;

            d.    1-[2-(4-morpholinyl)ethyl]-3-(2,2,3,3-tetramethylcyclopropoyl)indole, commonly known as A-796,260;

            e.    1-[(tetrahydropyran-4-yl)methyl]-3-(2,2,3,3-tetramethylcyclopropoyl)indole, commonly known as A-834,735;

         9.    Any compound structurally derived from N-adamantyl-1H-indole-3-carboxamide by substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the adamantyl ring to any extent. Substances specified under this subdivision include:

            a.    N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide, commonly known as 2NE1;

            b.    N-(1-adamantyl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide, commonly known as STS-135;

         10.    Any compound structurally derived from N-adamantyl-1H-indazole-3-carboxamide by substitution at either nitrogen atom of the indazole ring with alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indazole ring to any extent, whether or not substituted in the adamantyl ring to any extent. Substances specified under this subdivision include:

            a.    1-pentyl-N-(1-adamantyl)-1H-indazole-3-carboxamide, commonly known as AKB48;

            b.    1-(5-fluoropentyl)-N-(1-adamantyl)-1H-indazole-3-carboxamide, commonly known as 5F-AKB48.

         11.    Any compound structurally derived from N-naphthyl-1H-indazole-3-carboxamide by substitution at either nitrogen atom of the indazole ring with alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indazole ring to any extent, whether or not substituted in the naphthyl ring to any extent.

         12.    [1,1′-biphenyl]-3-yl-carbamic acid, cyclohexyl ester, commonly known as URB-602;

         13.    [(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl] acetate, commonly known as CP 50,556-1;

         14.    (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol, commonly known as HU-210;

         15.    (6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol, commonly known as HU-211;

         16.    3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-1,4-dione, commonly known as HU-331;

         17.    ((6aR,10aR)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-9-yl)methanol, commonly known as JWH-051;

         18.    (6aR,10aR)-3-(1,1-Dimethylbutyl)-6a,7,10,10a-tetrahydro -6,6,9-trimethyl-6H-dibenzo[b,d]pyran, commonly known as JWH-133;

         19.    (6aR,10aR)-1-methoxy-6,6,9-trimethyl-3-[(2R)-1,1,2-trimethylbutyl]-6a,7,10,10a-tetrahydrobenzo[c]chromene, commonly known as JWH-359;

         20.    Napthalen-1-yl-(4-pentyloxynapthalen-1-yl)methanone, commonly known as CB-13;

         21.    N-cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)-undecamide, commonly known as CB-25;

         22.    N-cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)-undecamide, commonly known as CB-52;

         23.    N-(benzo[1,3]dioxol-5-ylmethyl)-7-methoxy-2-oxo-8-pentyloxy-1,2-dihydroquinoline-3-carboxamide, commonly known as JTE-907;

         24.    N-[3-(2-methoxyethyl)-4,5-dimethyl-1,3-thiazol-2-ylidene]-2,2,3,3-tetramethylcyclopropane-1-carboxamide, commonly known as A-836,339;

         25.    Anthracen-9-yl{2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}methanone, commonly known as WIN 56,098;

         26.    6-methyl-2-[(4-methylphenyl)amino]-4H-3,1-benzoxazin-4-one, commonly known as URB-754;

         27.    [3-(3-carbamoylphenyl)phenyl] N-cyclohexylcarbamate, commonly known as URB-597;

         28.    (-)-(R)-3-(2-Hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluorobutyl-1-sulfonate, commonly known as BAY 38-7271.

         29.    Any compound structurally derived from 1H-indole-3-carboxylic acid quinolinyl ester by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the quinoline ring to any extent. Substances specified under this subdivision include:

            a.    1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester, commonly known as PB-22;

            b.    1-(5-fluoropentyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester, commonly known as 5F-PB-22;

            c.    1-(cyclohexylmethyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester, commonly known as BB-22.

         30.    Any compound structurally derived from N-naphthyl-1H-indole-3-carboxamide by substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the naphthyl ring to any extent. Substances specified under this subdivision include:

            a.    1-pentyl-N-(1-naphthyl)-1H-indole-3-carboxamide, commonly known as NNEI or MN-24;

            b.    1-(5-fluoropentyl)-N-(1-naphthyl)-1H-indole-3-carboxamide, commonly known as 5F-NNEI or 5F-MN-24.

         31.    Any compound structurally derived from 3-(pyridinoyl)indole by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the pyridine ring to any extent. Substances specified under this subdivision include:

            a.    1-pentyl-3-(3-pyridinoyl)indole;

            b.    1-(5-fluoropentyl)-3-(3-pyridinoyl)indole.

         32.    N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, commonly known as AB-FUBINACA.

         33.    N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide, commonly known as ADB-PINACA.

         34.    N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, commonly known as AB-CHMINACA.

         35.    N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide, commonly known as AB-PINACA).

         36.    [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone, commonly known as THJ-2201.

         37.    N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, commonly known as MAB-CHMINACA or ADB-CHMINACA.

         38.    Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, commonly known as 5F-ADB.

         38m.    Methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, commonly known as 4F-MDMB-BINACA or 4F-MDMB-BUTINACA.

         39.    Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, commonly known as 5F-AMB.

         40.    N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, commonly known as ADB-FUBINACA.

         41.    Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate commonly known as MDMB-CHMICA.

         42.    Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, commonly known as MDMB-FUBINACA.

         43.    Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, commonly known as FUB-AMB, MMB-FUBINACA or AMB-FUBINACA.

         43m.    Methyl 2-(1-(4-fluorobenzyl)-1H-indole-3-carboxamido)-3-methylbutanoate, commonly known as MMB-FUBICA or AMB-FUBICA.

         44.    Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate, commonly known as NM2201.

         45.    N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide, commonly known as 5F-AB-PINACA.

         46.    1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide, commonly known as 4-CN-CUMYL-BUTINACA.

         47.    Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate, commonly known as MMB-CHMICA.

         48.    1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide, commonly known as 5F-CUMYL-P7AICA.

         49.    Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, commonly known as 5F-EDMB-PINACA.

         50.    Methyl 2-(1-(5-fluoropentyl)-1-indole-3-carboxamido)-3,3-dimethylbutanoate, commonly known as 5F-MDMB-PICA.

         51.    N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, commonly known as FUB-AKB48, FUB-APINACA or AKB48 N-(4-FLUOROBENZYL).

         52.    1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide, commonly known as 5F-CUMYL-PINACA or SGT-25.

         53.    (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone, commonly known as FUB-144.

         54.    Methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate, commonly known as MDMB-4en-PINACA.

         55.    Methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate, commonly known as 4F-MDMB-BUTICA or 4F-MDMB-BICA.

         56.    N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxaminde, commonly known as ADB-4en-PINACA.

         57.    5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one, commonly known as CUMYL-PEGACLONE or SGT-151.

         58.    Ethyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate, commonly known as 5F-EDMB-PICA or 5F-EDMB-2201.

      (u)    1-[1-(2-thienyl)cyclohexyl]piperidine, which is the thiophene analog of phencyclidine;

      (ud)    1-[1-(2-thienyl)cyclohexyl]pyrrolidine, which is the thiophene pyrrolidine analog of phencyclidine;

      (ug)    N-ethyl-1-phenylcyclohexylamine, which is the ethylamine analog of phencyclidine;

      (ur)    1-(1-phenylcyclohexyl)pyrrolidine, which is the pyrrolidine analog of phencyclidine;

      (uv)    2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone, commonly known as methoxetamine.

      (v)    2,5-dimethoxyamphetamine;

      (w)    4-bromo-2,5-dimethoxyamphetamine, commonly known as “DOB”;

      (wa)    4-iodo-2,5-dimethoxyamphetamine, commonly known as DOI.

      (wb)    4-chloro-2,5-dimethoxyamphetamine, commonly known as DOC.

      (wg)    4-bromo-2,5-dimethoxy-beta-phenylethylamine, commonly known as “2C-B” or “Nexus”;

      (wgm)    4-iodo-2,5-dimethoxy-beta-phenylethylamine, commonly known as “2C-I”.

      (wh)    2,5 dimethoxy-4-(n)-propylthiophenethylamine, commonly known as “2C-T-7”;

      (wi)    Alpha-methyltryptamine, commonly known as “AMT”;

      (wj)    5-methoxy-N, N-diisopropyltryptamine, commonly known as “5-MeO-DIPT”;

      (wk)    2,5-dimethoxy-4-ethylphenethylamine, commonly known as 2C-E.

      (wL)    2,5-dimethoxy-4-methylphenethylamine, commonly known as 2C-D.

      (wm)    2,5-dimethoxy-4-chlorophenethylamine, commonly known as 2C-C.

      (wn)    2,5-dimethoxy-4-ethylthiophenethylamine, commonly known as 2C-T-2.

      (wo)    2,5-dimethoxy-4-isopropylthiophenethylamine, commonly known as 2C-T-4.

      (wp)    2,5-dimethoxyphenethylamine, commonly known as 2C-H.

      (wq)    2,5-dimethoxy-4-nitrophenethylamine, commonly known as 2C-N.

      (wr)    2,5-dimethoxy-4-(n)-propylphenethylamine, commonly known as 2C-P.

      (ws)    Any compound structurally derived from N-benzyl-2-(2,5-dimethoxyphenyl)ethanamine by substitution at the nitrogen atom, or on either ring, with alkyl, alkoxy, alkylenedioxy, haloalkyl, hydroxyl, halide or nitro substituents, or by any combination of these modifications. Substances specified under this paragraph include:

         1.    2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine, commonly known as 25I-NBOMe.

         2.    2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine, commonly known as 25C-NBOMe.

         3.    2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine, commonly known as 25B-NBOMe.

         4.    2-(4-ethyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine, commonly known as 25E-NBOMe.

      (wv)    N,N-diallyl-5-methoxytryptamine, commonly known as 5-MeO-DALT.

      (ww)    5-(2-aminopropyl)benzofuran, commonly known as 5-APB.

      (wx)    6-(2-aminopropyl)benzofuran, commonly known as 6-APB.

      (wy)    5-(2-aminopropyl)-2,3-dihydrobenzofuran, commonly known as 5-APDB.

      (wz)    6-(2-aminopropyl)-2,3-dihydrobenzofuran, commonly known as 6-APDB.

      (x)    4-methoxyamphetamine, commonly known as “PMA.”

      (xa)    5-iodo-2-aminoindane, commonly known as 5-IAI.

      (xb)    4-methoxymethamphetamine, commonly known as PMMA.

   (5)   Depressants. Any material, compound, mixture or preparation which contains any quantity of any of the following substances having a depressant effect on the central nervous system, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:

      (aa)    Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4 H -benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine).

      (ab)    Diclazepam (7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2 H -benzo[ e][1,4]diazepin-2-one).

      (ac)    Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6 H -thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine).

      (ad)    Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4 H -benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine).

      (ae)    Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methly-4 H -benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine).

      (ag)    Gamma-hydroxybutyric acid (commonly known as gamma hydroxybutyrate or “GHB”), gamma-butyrolactone, and 1,4-butanediol.

      (am)    Mecloqualone.

      (b)    Methaqualone.

   (7)   Stimulants. Any material, compound, mixture or preparation which contains any quantity of any of the following substances having a stimulant effect on the central nervous system, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:

      (ag)    Cathinone.

      (am)    Aminorex.

      (b)    Fenethylline.

      (c)    N-ethylamphetamine.

      (cm)    4,4′-Dimethylaminorex.

      (d)    4-methylaminorex.

      (e)    N,N-dimethylamphetamine.

      (L)    Substituted cathinones. Any compound, except bupropion or compounds scheduled elsewhere in this chapter, that is structurally derived from 2-amino-propan-1-one by substitution at the 1-position with either phenyl, napthyl, or thiophene ring systems, whether or not the compound is further modified in any of the following ways: by substitution in the ring system to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents; by substitution at the 3-position with an acyclic alkyl substituent; by substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups; by inclusion of the 2-amino nitrogen atom in a cyclic structure; or by any combination of these modifications. Substances specified under this subdivision include:

         1.    Methcathinone.

         2.    Methylenedioxypyrovalerone, commonly known as MDPV.

         3.    4-methylmethcathinone, commonly known as mephedrone or 4-MMC.

         4.    4-methylethcathinone, commonly known as 4-MEC.

         5.    4-methoxy-alpha-pyrrolidinopropiophenone, commonly known as MOPPP.

         6.    3,4-methylenedioxy-alpha-pyrrolidinopropiophenone, commonly known as MDPPP.

         7.    Alpha-pyrrolidinovalerophenone, commonly known as alpha-PVP.

         8.    2-fluoromethcathinone, commonly known as 2-FMC.

         9.    3-fluoromethcathinone, commonly known as 3-FMC.

         10.    4-fluoromethcathinone, commonly known as 4-FMC or flephedrone.

         11.    3,4-methylenedioxymethcathinone, commonly known as methylone or bk-MDMA.

         12.    Naphthylpyrovalerone, commonly known as naphyrone.

         13.    4-methyl-alpha-pyrrolidinobutiophenone, commonly known as MPBP.

         14.    4-methoxymethcathinone, commonly known as methedrone or bk-PMMA.

         15.    Ethcathinone.

         16.    3,4-methylenedioxyethcathinone, commonly known as ethylone or bk-MDEA.

         17.    beta-Keto-N-methylbenzodioxolylbutanamine, commonly known as butylone or bk-MBDB.

         18.    N,N-dimethylcathinone, commonly known as metamfepramone.

         19.    Alpha-pyrrolidinopropiophenone, commonly known as alpha-PPP.

         20.    3-methoxymethcathinone, commonly known as 3-MMC.

         21.    4-ethylmethcathinone, commonly known as 4-EMC.

         22.    3,4-dimethylmethcathinone, commonly known as 3,4-DMMC.

         23.    beta-Keto-N-methylbenzodioxolylpentanamine, commonly known as pentylone or bk-MBDP.

         24.    beta-Keto-ethylbenzodioxolylbutanamine, commonly known as eutylone or bk-EBDB.

         25.    4-bromomethcathinone, commonly known as 4-BMC.

         26.    Alpha-methylamino-butyrophenone, commonly known as buphedrone or MABP.

         27.    3,4-methylenedioxy-alpha-pyrrolidinobutiophenone, commonly known as MDPBP.

         28.    4-methyl-alpha-pyrrolidinohexiophenone, commonly known as MPHP.

         29.    N,N-dimethyl-3,4-methylenedioxycathinone.

         30.    N,N-diethyl-3,4-methylenedioxycathinone.

         31.    Alpha-methylamino-valerophenone, commonly known as pentedrone.

         32.    4-methyl-alpha-pyrrolidinopropiophenone, commonly known as 4-MePPP.

         33.    Alpha-pyrrolidinobutiophenone, commonly known as a-PBP.

         34.    N-Ethylpentylone, commonly known as ephylone.

         35.    N-Ethylhexedrone.

         36.    Alpha-pyrrolidinohexanophenone, commonly known as a-PHP.

         37.    4-methyl-alpha-ethylainopentiophenone, commonly known as 4-MEAP.

         38.    4′-methyl-alpha-pyrrolidinohexiophenone, commonly known as MPHP.

         39.    Alpha-pyrrolidinoheptaphenone, commonly known as PV8.

         40.    4′-chloro-alpha-pyrrolidinovalerophenone, commonly known as 4-chloro-a-PVP.

      (mk)    Mitragynine.

      (mL)    7-hydroxymitragynine.

      (mm)    5,6-methylenedioxy-2-aminoindane, commonly known as MDAI.

      (mn)    Benzothiophenylcyclohexylpiperidine, commonly known as BTCP.

      (p)    4-methylthioamphetamine, commonly known as “4-MTA.”

      (q)    N- benzylpiperazine, commonly known as “BZP.”

      (r)    7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid, commonly known as Amineptine.

      (s)    N-phenyl-N’-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate, commonly known as Mesocarb.

      (t)    N-methyl-1-(thiophen-2-yl)propan-2-amine, commonly known as Methiopropamine.